News

Satellos said that following the Phase I data, it will be advancing its DMD small molecule to a Phase II trial.
Subjects who can tolerate the treatment can continue until the progression of the disease is observed. Credit: Power ...
Merck KGaA said that cohort A met the primary endpoint in the Phase II lupus trial but cohort B failed to meet its primary ...
AnnJi Pharmaceutical has reported encouraging outcomes from its randomised, placebo-controlled Phase I/IIa trial of AJ201.
The US FDA has cleared Grifols' investigational new drug (IND) application to commence a Phase II trial of GRF312 Ophthalmic ...
Member states of the World Health Organization (WHO) have recently agreed on the world's first Pandemic Agreement.
Queen's Health Sciences (QHS) in Canada has announced the launch of a centralised Clinical Trial Support Unit (CTSU).
KaliVir Immunotherapeutics has concluded the first cohort in the Phase I/Ib STEALTH-001 trial evaluating VET3-TGI for ...
Zura Bio has launched the Phase II TibuSHIELD trial of tibulizumab for moderate to severe hidradenitis suppurativa (HS).
Viridian Therapeutics’ veligrotug has shown one-year durability in a Phase III trial in patients with active thyroid eye ...
Accropeutics said the Phase II trial of AC-201 will support the drugs progression to a Phase III trial in plaque psoriasis.
At the Outsourcing in Clinical Trials East Coast 2025 conference in King of Prussia, panelists were asked how trial sponsors ...